FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) ...
Achieving Weight Loss: New Study Identifies Key Factors of Success
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
Managed Healthcare Executive1d
FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.
FierceBiotech1d
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference
Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...
FierceBiotech2d
Capricor sells Europe rights to DMD therapy for $35M as FDA application approaches
Having already scooped up the U.S. rights to Capricor Therapeutics’ late-stage Duchenne muscular dystrophy (DMD) therapy, ...
Managed Healthcare Executive2d
FDA Approves Ebglyss for Treatment of Moderate to Severe Atopic Dermatitis
The FDA has approved Lilly’s Ebglyss (lebrikizumab-lbkz) for the treatment of moderate to severe atopic dermatitis in adults ...
WIBC2d
FDA Approves Eli Lilly Treatment for Eczema
INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...
MassDevice2d
FDA approves enhanced Philips LumiGuide endovascular navigation wire
Philips (NYSE: PHG) announced today that it introduced the FDA-approved, 160 cm version of its LumiGuide endovascular ...
These Apple Devices Are Now FDA-Approved
Over the past week, the FDA cleared two of Apple's new health features: The agency approved AirPods Pro 2's new hearing-aid ...